Quasispecies complexity and long-term outcomes in hemophiliacs with HCV/HIV coinfection.

被引：0
|
作者：
Sherman, KE
Rouster, SD
Eyster, ME
机构：
[1] UNIV CINCINNATI,MED CTR,DEPT MED,CINCINNATI,OH 45267
[2] PENN STATE UNIV,COLL MED,HERSHEY,PA
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [1] Effect of protease inhibitors on liver function in hemophiliacs with HIV-HCV coinfection.
    Seto, Y
    Higasa, S
    Ueda, M
    Kataoka, Y
    Nakata, A
    Nakamura, Y
    Masui, H
    Iwata, N
    Suehiro, A
    Kakishita, E
    HEPATOLOGY, 1997, 26 (04) : 736 - 736
  • [2] The role of HAART on HCV disease severity in HIV/HCV coinfection.
    Hassanein, TI
    Aronson, N
    Behling, C
    Torriani, F
    Chatfield, ER
    Chen, P
    Mathews, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1446 - A1446
  • [3] Impact of HAART on survival of patients with HCV/HIV coinfection.
    Oliver, D
    Barber, E
    Chatfield, E
    Stewart, M
    Selim, K
    Mathews, C
    Hassanein, T
    HEPATOLOGY, 2002, 36 (04) : 567A - 567A
  • [4] Achalasia in a patient with HIV/HCV coinfection. Detection of HCV in the esophageal tissue
    Gockel, H. R.
    Gockel, I.
    Drescher, D. G.
    Mueller, H.
    Schad, A.
    Kittner, J. M.
    Rossmann, H.
    Lang, H.
    CHIRURG, 2011, 82 (11): : 1021 - 1026
  • [5] HIV protease inhibitors do not reduce hepatitis C virus (HCV) replication in patients with HIV and HCV coinfection.
    Erhardt, A
    Mauss, S
    Adams, O
    Jablonowski, H
    Niederau, C
    Haussinger, D
    HEPATOLOGY, 1997, 26 (04) : 737 - 737
  • [6] Interleukin-2 therapy as novel approach for the treatment of HIV/HBV and HIV/HCV coinfection.
    Schlaak, JF
    Radecke, K
    HEPATOLOGY, 1998, 28 (04) : 507A - 507A
  • [7] Comparison of health related quality of life (HRQOL) in hepatitis C (HCV) infection, HIV infection and HCV/HIV coinfection.
    Fleming, C
    Christiansen, D
    Heeren, T
    Craven, DE
    Horsburgh, R
    Nunes, D
    HEPATOLOGY, 2002, 36 (04) : 559A - 559A
  • [8] THE PREVALENCE AND IMPACT OF HEPATIC STEATOSIS ON RESPONSE TO DAA THERAPY IN HIV-HCV COINFECTION.
    Johnson, Leigh P.
    Sterling, Richard K.
    HEPATOLOGY, 2019, 70 : 964A - 965A
  • [9] The clinical significance of hepatitis C virus (HCV) in human immunodeficiency virus (HIV) coinfection.
    Sterling, RK
    Orenstein, R
    Contos, MJ
    Luketic, VA
    Sanyal, AJ
    Stravitz, RT
    Mills, AS
    Shiffman, ML
    HEPATOLOGY, 2001, 34 (04) : 436A - 436A
  • [10] HCV quasispecies evolution: association with proggession to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV
    Qin, HX
    Shire, NJ
    Keenan, ED
    Rouster, SD
    Eyster, ME
    Goederl, JJ
    Koziel, MJ
    Sherman, KE
    BLOOD, 2005, 105 (02) : 533 - 541
12345